OCUL
Ocular Therapeutix·NASDAQ
--
--(--)
--
--(--)
6.28 / 10
Outperform
Analyst sentiment is overwhelmingly bullish (Strong Buy across 4 reports), and money flow is robust (7.65/10). Medium and Large flows are positive, though overall fund trend is negative. This blend of strong analyst conviction and healthy inflows counteracts some fundamental weaknesses, supporting the recent price pop.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-09
InstitutionChardan Capital
Times predicted4
Historical Win Rate50.0%
What is the market sentiment for OCUL?
- OCUL holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.28/10 (Outperform).
